µþ°ùø»å°ì°ù³Ü³¾³¾±ð Forside DBV Technologies DBV Technologies Develops patches for desensitization of food allergy using epicutaneous delivery. The lead program is in late stage clinical trials for peanut allergy desensitization. Âé¶¹Éç BioCapital ±õ²Ô±¹±ð²õ³Ù±ð°ù¾±²Ô²µ²õÃ¥°ù 2010 IPO in 2013 – DBV (Euronext Paris) Lokation Bagneux, Ill-de-France, France